Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, Q2 2026
5,055
Period ended Jun 30, 2026
Change on a year earlier
+5.7%
4,781 in Q2 2025
History
69 quarters
Since Q4 2008
Sources
67
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accounts receivable, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 5,055 | +5.7% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,741 | +8.0% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 4,913 | +11.2% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 5,095 | +11.1% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 4,781 | +2.5% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 4,388 | -6.0% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 4,420 | -5.2% | Form 10-K (filed 2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 4,587 | -4.2% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 4,663 | +10.3% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 4,669 | +12.2% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 4,660 | -2.4% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 4,790 | +10.0% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 4,229 | +2.7% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 4,162 | +9.9% | Form 10-Q (filed 2023-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 4,777 | +6.3% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 4,354 | -4.6% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,118 | -0.7% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 3,787 | -3.5% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 4,493 | -8.2% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 4,566 | +16.7% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 4,149 | +29.9% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 3,925 | +0.5% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 4,892 | +36.6% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 3,913 | +18.0% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 3,194 | -5.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 3,907 | +19.0% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,582 | +7.7% | Form 10-K (filed 2020-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,315 | -4.3% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 3,396 | -4.1% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 3,283 | -13.0% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 3,327 | -13.6% | Form 10-K (filed 2019-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,465 | -15.9% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 3,541 | -20.9% | Form 10-Q (filed 2018-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 3,775 | -6.4% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 3,851 | -14.7% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 4,122 | -18.8% | Form 10-Q (filed 2017-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 4,478 | -22.1% | Form 10-Q (filed 2017-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 4,034 | -34.5% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 4,514 | -22.9% | Form 10-K (filed 2017-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 5,075 | -16.9% | Form 10-Q (filed 2016-11-07) ↗ |
| Q2 2016 | Jun 30, 2016 | 5,752 | +7.9% | Form 10-Q (filed 2016-08-05) ↗ |
| Q1 2016 | Mar 31, 2016 | 6,163 | +27.5% | Form 10-Q (filed 2016-05-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 5,854 | +26.3% | Form 10-K (filed 2016-02-24) ↗ |
| Q3 2015 | Sep 30, 2015 | 6,105 | +114.2% | Form 10-Q (filed 2015-11-04) ↗ |
| Q2 2015 | Jun 30, 2015 | 5,331 | +55.1% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 4,835 | +49.4% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 4,635 | +112.4% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2014 | Sep 30, 2014 | 2,850 | +44.6% | SEC Filing ↗ |
| Q2 2014 | Jun 30, 2014 | 3,437 | +81.3% | SEC Filing ↗ |
| Q1 2014 | Mar 31, 2014 | 3,236 | +66.4% | SEC Filing ↗ |
| Q4 2013 | Dec 31, 2013 | 2,182 | +24.6% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2013 | Sep 30, 2013 | 1,972 | +11.7% | Form 10-Q (filed 2013-10-31) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,896 | +11.3% | Form 10-Q (filed 2013-08-01) ↗ |
| Q1 2013 | Mar 31, 2013 | 1,945 | -10.1% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,751 | -10.2% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,766 | -5.4% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,703 | -12.2% | Form 10-Q (filed 2012-08-01) ↗ |
| Q1 2012 | Mar 31, 2012 | 2,164 | +20.1% | Form 10-Q (filed 2012-05-04) ↗ |
| Q4 2011 | Dec 31, 2011 | 1,951 | +20.3% | Form 10-K (filed 2012-02-23) ↗ |
| Q3 2011 | Sep 30, 2011 | 1,867 | +11.8% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 1,939 | – | Form 10-Q (filed 2011-08-05) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,801 | +20.8% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2010 | Dec 31, 2010 | 1,622 | +16.7% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,670 | +24.7% | Form 10-Q (filed 2010-11-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,491 | – | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,390 | +35.8% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 1,339 | – | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,243 | – | Form 10-Q (filed 2009-08-05) ↗ |
| Q4 2008 | Dec 31, 2008 | 1,023 | – | Form 10-Q (filed 2009-08-05) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Accounts receivable, net ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_ar
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.